Primer: Sionna Therapeutics (SION US) - Aug 2026
Sionna Therapeutics is a clinical-stage biopharmaceutical company sharply focused on developing novel small-molecule therapies for cystic...
103 Views
𝛼SK or SearchENTITY
Sionna Therapeutics (SION US)
Sionna Therapeutics (SION US)
8
Analysis
Health Care • United States
Clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (“CF”) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (“CFTR”) protein to deliver clinically meaningful benefit to CF patients.
morex